<VariationArchive RecordType="classified" VariationID="16414" VariationName="NC_000004.12:g.(154580323_154580329)_(154590210_154590216)del" VariationType="Deletion" Accession="VCV000016414" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-24" DateCreated="2014-10-01" MostRecentSubmission="2014-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31453" VariationID="16414">
      <GeneList>
        <Gene Symbol="FGA" FullName="fibrinogen alpha chain" GeneID="2243" HGNC_ID="HGNC:3661" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>4q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="154583126" stop="154590742" display_start="154583126" display_stop="154590742" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="155504279" stop="155511896" display_start="155504279" display_stop="155511896" Strand="-" />
          </Location>
          <OMIM>134820</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000004.12:g.(154580323_154580329)_(154590210_154590216)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4q28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" outerStart="154580323" innerStart="154580329" innerStop="154590210" outerStop="154590216" display_start="154580323" display_stop="154590216" variantLength="9882" Strand="-" />
      </Location>
      <OtherNameList>
        <Name>11-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.(154580323_154580329)_(154590210_154590216)del" Assembly="GRCh38">
            <Expression>NC_000004.12:g.(154580323_154580329)_(154590210_154590216)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="nssv1415021" DB="dbVar" />
        <XRef ID="nsv513793" DB="dbVar" />
        <XRef Type="Allelic variant" ID="134820.0019" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 10602365 Fig. 2a to determine the location of this allele on the current reference sequence.</Comment>
      <Comment DataSource="NCBI curation" Type="public">Approx. 9.9-kb genomic deletion beginning in intron 1 of FGA and ending beyond the 3'-end of the gene.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000004.12:g.(154580323_154580329)_(154590210_154590216)del AND Congenital afibrinogenemia" Accession="RCV000017876" Version="28">
        <ClassifiedConditionList TraitSetID="5332">
          <ClassifiedCondition DB="MedGen" ID="C2584774">Congenital afibrinogenemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2000-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2000-07-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2014-10-01" MostRecentSubmission="2014-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10602365</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10891444</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5332" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12543" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital afibrinogenemia</ElementValue>
                <XRef ID="MONDO:0008737" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5761" />
                <XRef ID="5761" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="335" DB="Orphanet" />
              <XRef ID="98880" DB="Orphanet" />
              <XRef ID="C2584774" DB="MedGen" />
              <XRef ID="MONDO:0008737" DB="MONDO" />
              <XRef Type="MIM" ID="202400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38155" SubmissionDate="2014-09-29" DateLastUpdated="2014-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="134820.0019_AFIBRINOGENEMIA, CONGENITAL" title="FGA, 11-KB DEL_AFIBRINOGENEMIA, CONGENITAL" />
        <ClinVarAccession Accession="SCV000038155" DateUpdated="2014-10-01" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a nonconsanguineous Swiss family with congenital afibrinogenemia (202400), Neerman-Arbez et al. (1999) demonstrated that 4 affected males (2 brothers and their 2 first cousins) were homozygous for a deletion of approximately 11 kb from the FGA gene. Haplotype data suggested that deletions occurred separately, on 3 distinct ancestral chromosomes, implying that the FGA region is susceptible to deletion by a common mechanism. This was said to be the first known causative mutation for congenital afibrinogenemia. Neerman-Arbez et al. (1999) found that all 3 deletions were identical to the level of the basepair and probably resulted from nonhomologous (illegitimate) recombination. The centromeric and telomeric deletion junctions featured both a 7-bp direct repeat, AACTTTT, situated in FGA intron 1 and in the FGA-FGB (134830) intergenic sequence, and a number of inverted repeats that could be involved in the generation of secondary structures. Analysis with closely linked flanking polymorphic markers revealed the existence of at least 2 haplotypes, further suggesting independent origins of the deletions in this family.</Attribute>
              <Citation>
                <ID Source="PubMed">10602365</ID>
              </Citation>
              <XRef DB="OMIM" ID="202400" Type="MIM" />
              <XRef DB="OMIM" ID="134830" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Neerman-Arbez et al. (2000) collected data on 13 additional unrelated patients with congenital afibrinogenemia to identify the causative mutations and to determine the prevalence of the 11-kb deletion. A common recurrent mutation at the donor splice site of FGA intron 4 (IVS4G-T+1; 134820.0020) accounted for 14 of the 26 (54%) alleles. One patient was heterozygous for the 11-kb deletion. Neerman-Arbez et al. (2000) stated that 86% of afibrinogenemia alleles analyzed to that time had truncating mutations of FGA, although mutations in all 3 fibrinogen genes, FGG, FGA, and FGB, might be predicted to cause congenital afibrinogenemia.</Attribute>
              <Citation>
                <ID Source="PubMed">10891444</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FGA" />
          </GeneList>
          <Name>FGA, 11-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">11-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="134820.0019" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AFIBRINOGENEMIA, CONGENITAL</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="38155" TraitType="Disease" MappingType="Name" MappingValue="AFIBRINOGENEMIA, CONGENITAL" MappingRef="Preferred">
        <MedGen CUI="C2584774" Name="Congenital afibrinogenemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

